文献速递术前评估与围术期医学疼痛医学

术中右美托咪定与瑞芬太尼镇痛比较:系统评价与Meta分析及试验序贯分析

Intra-operative analgesia with remifentanil vs. dexmedetomidine: a systematic review and meta-analysis with trial sequential analysis.
PubMed 文献 · Anaesthesia · 2019-04-05

结果显示右美托咪定组术后2小时静息疼痛评分更低(均差-0.7,95%CI -1.2至-0.2),且低血压、寒战和术后恶心呕吐发生率至少为瑞芬太尼组的两倍。

要点

  • 与瑞芬太尼相比,术中右美托咪定可降低术后24小时内疼痛评分。
  • 右美托咪定组术后需要阿片类药物和补救镇痛更少,首次镇痛请求时间更长。
  • 瑞芬太尼组低血压、寒战和术后恶心呕吐发生率至少为右美托咪定组的两倍。

核心结论

  • 与瑞芬太尼相比,全麻术中应用右美托咪定可改善术后24小时内的疼痛结局,且副作用更少,证据质量为中等。

研究设计与样本

  • 主要结局为术后2小时静息疼痛评分(视觉模拟量表,0-10分),Meta分析主要采用随机效应模型。

主要发现

  • 右美托咪定组术后2小时静息疼痛评分更低,均差(95%CI)为-0.7(-1.2至-0.2),I2=85%,p=0.004,证据质量中等。
  • 右美托咪定组术后24小时静息疼痛评分等次要疼痛结局也显著更优。
  • 瑞芬太尼组低血压、寒战和术后恶心呕吐发生率至少为右美托咪定组的两倍。
  • 右美托咪定组首次镇痛请求时间更长,术后吗啡用量和补救镇痛更少,而两组心动过缓发生率相似。

临床怎么用

  • 全麻术中可考虑以右美托咪定替代瑞芬太尼,以改善术后24小时内疼痛结局并减少低血压、寒战和术后恶心呕吐。

局限性

  • 术后2小时静息疼痛评分的合并分析异质性较高(I2=85%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intra-operative remifentanil is associated with increased postoperative analgesic requirements and opioid consumption. Dexmedetomidine has characteristics suggesting it may substitute for intra-operative remifentanil during general anaesthesia, but existing literature has reported conflicting results. We undertook this meta-analysis to investigate whether general anaesthesia including dexmedetomidine would result in less postoperative pain than general anaesthesia including remifentanil. The MEDLINE and PubMed electronic databases were searched up to October 2018. Only randomised trials including patients receiving general anaesthesia and comparing dexmedetomidine with remifentanil administration were included. Meta-analyses were performed mostly employing a random effects model. The primary outcome was pain score at rest (visual analogue scale, 0-10) at two postoperative hours. The secondary outcomes included: pain score at rest at 24 postoperative hours; opioid consumption at 2 and 24 postoperative hours; and rates of hypotension, bradycardia, shivering and postoperative nausea and vomiting. Twenty-one randomised trials, including 1309 patients, were identified. Pain scores at rest at two postoperative hours were lower in the dexmedetomidine group, with a mean difference (95%CI) of -0.7 (-1.2 to -0.2), I2 = 85%, p = 0.004, and a moderate quality of evidence. Secondary pain outcomes were also significantly better in the dexmedetomidine group. Rates of hypotension, shivering and postoperative nausea and vomiting were at least twice as frequent in patients who received remifentanil. Time to analgesia request was longer, and use of postoperative morphine and rescue analgesia were less, with dexmedetomidine, whereas episodes of bradycardia were similar between groups. There is moderate evidence that intra-operative dexmedetomidine during general anaesthesia improves pain outcomes during the first 24 postoperative hours, when compared with remifentanil, with fewer side effects.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Grape S, Kirkham KR, Frauenknecht J, et al. Intra-operative analgesia with remifentanil vs. dexmedetomidine: a systematic review and meta-analysis with trial sequential analysis. Anaesthesia. 2019. PMID: 30950522. doi:10.1111/anae.14657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。